Regions :: North America :: U.S.
Solazyme reports higher revenue, updates start-up timeline for first commercial plant
11:53 AM MST | November 6, 2013 | Rebecca Coons
Algal oils firm Solazyme (San Francisco) reports a net loss of $30.7 million for its fiscal third quarter compared with a net loss of $22.5 million in the year-ago period. Excluding one-time charges, the company reports a loss of 34 cts/share, missing a consensus of analysts' estimates compiled by Thomson Reuters (New York) by 1 ct. Sales increased 23.2% year-on-year, to $10.6 million. The company also announced that start-up of its first commercial-scale asset—a $140-million, 100,000-m.t./year joint venture facility with agrobusiness giant Bunge at Moema...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee